197 related articles for article (PubMed ID: 1776456)
1. Quantification of arylsulfatase B activity and diagnosis of Maroteaux-Lamy syndrome.
Hwu WL; Wang TR
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1991; 32(5):280-5. PubMed ID: 1776456
[TBL] [Abstract][Full Text] [Related]
2. Arylsulfatases A and B in metachromatic leukodystrophy and Maroteaux-Lamy syndrome: studies with 4-methylumelliferyl sulfate.
Kolodny EH; Mumford RA
Adv Exp Med Biol; 1976; 68():239-51. PubMed ID: 7105
[TBL] [Abstract][Full Text] [Related]
3. Prenatal diagnosis of Maroteaux-Lamy syndrome.
Van Dyke DL; Fluharty AL; Schafer IA; Shapiro LJ; Kihara H; Weiss L
Am J Med Genet; 1981; 8(2):235-42. PubMed ID: 6792921
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of arylsulfatase B in 2 brothers aged 40 and 38 years (Maroteaux-Lamy syndrome, type B).
Pilz H; von Figura K; Goebel HH
Ann Neurol; 1979 Oct; 6(4):315-25. PubMed ID: 122048
[TBL] [Abstract][Full Text] [Related]
5. Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation.
Krivit W; Pierpont ME; Ayaz K; Tsai M; Ramsay NK; Kersey JH; Weisdorf S; Sibley R; Snover D; McGovern MM
N Engl J Med; 1984 Dec; 311(25):1606-11. PubMed ID: 6150438
[TBL] [Abstract][Full Text] [Related]
6. Mental retardation in a patient with Maroteaux-Lamy.
Vestermark S; Tønnesen T; Andersen MS; Güttler F
Clin Genet; 1987 Feb; 31(2):114-7. PubMed ID: 3103957
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI].
Zheng J; Huang Y; Zhao X; Sheng H; Cheng J; Zhou Z; Li X; Mao X; Liu L
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):403-8. PubMed ID: 25190157
[TBL] [Abstract][Full Text] [Related]
8. Arylsulfatases A and B in EBV-transformed lymphoid cell lines: studies on their molecular forms in cells from patients with inborn sulfatase deficiencies. Comparative diagnostic value of enzymatic assays.
Tempesta MC; Levade T; Salvayre R
Clin Chim Acta; 1991 Oct; 202(3):149-65. PubMed ID: 1687673
[TBL] [Abstract][Full Text] [Related]
9. [The early diagnosis of Maroteaux-Lamy syndrome with confirmation of arylsulphatase deficiency].
Van Biervliet JP; Van Leeuwen EF; Abeling NG; De Jonge HF; Liem KO; Wadman SK
Arch Fr Pediatr; 1977 Apr; 34(4):362-70. PubMed ID: 142458
[TBL] [Abstract][Full Text] [Related]
10. Postnatal and prenatal diagnosis of Maroteaux-Lamy syndrome.
Rogoyski A; Czartoryska B; Kleijer WJ; Niermeijer MF; Tronowska TD; Gorska D; Polatynska-Krzyspiak B; Zaremba J
Acta Anthropogenet; 1985; 9(1-3):109-16. PubMed ID: 3939668
[TBL] [Abstract][Full Text] [Related]
11. [Maroteaux-Lamy syndrome: a case report].
Mtar A; Charfeddine B; Braham I; Ben Abdallah J; Neffati S; Smach MA; Bourfifa Z; Ksouri M; Dridi H; Limem K
Ann Biol Clin (Paris); 2011; 69(6):693-7. PubMed ID: 22123570
[TBL] [Abstract][Full Text] [Related]
12. Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome.
Jezyk PF; Haskins ME; Patterson DF; Mellman WJ; Greenstein M
Science; 1977 Nov; 198(4319):834-6. PubMed ID: 144321
[TBL] [Abstract][Full Text] [Related]
13. Maroteaux-Lamy syndrome.
Lakhotia S; Sharma A; Shrivastava GP; Jain SK
Indian J Pediatr; 2004 Oct; 71(10):933-5. PubMed ID: 15531839
[TBL] [Abstract][Full Text] [Related]
14. Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B.
Wicker G; Prill V; Brooks D; Gibson G; Hopwood J; von Figura K; Peters C
J Biol Chem; 1991 Nov; 266(32):21386-91. PubMed ID: 1718978
[TBL] [Abstract][Full Text] [Related]
15. Abnormal granulation of blood granulocytes in mucopolysaccharidosis VI-a case report.
Krishnagiri C; Ajanahalli RR; Kashyap S; Anegundi R; Boranaik L
Ann Diagn Pathol; 2013 Feb; 17(1):137-9. PubMed ID: 22056033
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of Maroteaux-Lamy syndrome by the use of radiolabelled oligosaccharides as substrates for the determination of arylsulphatase B activity.
Hopwood JJ; Elliott H; Muller VJ; Saccone GT
Biochem J; 1986 Mar; 234(3):507-14. PubMed ID: 3087346
[TBL] [Abstract][Full Text] [Related]
17. Juvenile form of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). A C-terminal extension causes instability but increases catalytic efficiency of arylsulfatase B.
Arlt G; Brooks DA; Isbrandt D; Hopwood JJ; Bielicki J; Bradford TM; Bindloss-Petherbridge CA; von Figura K; Peters C
J Biol Chem; 1994 Apr; 269(13):9638-43. PubMed ID: 8144552
[TBL] [Abstract][Full Text] [Related]
18. Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes.
Isbrandt D; Arlt G; Brooks DA; Hopwood JJ; von Figura K; Peters C
Am J Hum Genet; 1994 Mar; 54(3):454-63. PubMed ID: 8116615
[TBL] [Abstract][Full Text] [Related]
19. Maroteaux-Lamy syndrome in a large consanguineous kindred: biochemical and immunological studies.
Black SH; Pelias MZ; Miller JB; Blitzer MG; Shapira E
Am J Med Genet; 1986 Oct; 25(2):273-9. PubMed ID: 3096137
[TBL] [Abstract][Full Text] [Related]
20. Arylsulphatase B studies in skin fibroblasts from patients with Maroteaux--Lamy syndrome with special reference to electrophoretic mobility and prenatal diagnosis.
Schwartz M; Brandt NJ; Christensen E; Pedersen C
J Inherit Metab Dis; 1980; 3(3):99-100. PubMed ID: 6775150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
